m+Medelevator.RU
← Поиск публикаций
Clinical & experimental optometry · 2026

Changes in inflammatory blood parameters in patients with radiation-related complications due to radiotherapy for uveal melanoma.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Algedik Tokyürek Merve Özge, Koç İrem, Öztürk Ebru, Yazıcı Gözde, Kıratlı Hayyam

Аннотация

CLINICAL RELEVANCE: Radiation retinopathy is a common cause of visual impairment following ocular radiotherapy, and systemic inflammatory activity may contribute to retinal vascular damage. Understanding inflammatory mechanisms may support earlier identification of patients at risk and improve clinical monitoring strategies.

BACKGROUND: Radiation retinopathy is a vision-threatening complication of radiotherapy for uveal melanoma and has traditionally been considered a localised microvascular disorder. However, the potential contribution of systemic inflammation to its development remains unclear.

METHODS: A retrospective review was undertaken of hospital records of patients diagnosed with radiation retinopathy after stereotactic photon radiotherapy for uveal melanoma. Demographic characteristics, tumour features, and systemic inflammatory blood parameters were evaluated before and after the onset of retinopathy.

RESULTS: A total of 97 patients were included, with 52.6% female participants. Most tumours were classified as T1 or T2. The median time to retinopathy diagnosis was 24 months. All systemic inflammatory blood parameters showed significant increases after the development of radiation retinopathy (all p < 0.05).

CONCLUSION: It is concluded that radiation retinopathy is associated with systemic inflammatory activation, suggesting that inflammatory processes may extend beyond localised retinal injury, and therefore may serve as accessible biomarkers for disease monitoring.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты